Stock & Company Details
Alzamend Neuro Inc $ALZN
Price:
N/A
N/A
4.8M
$6.5M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.47
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALZN technical indicators
Latest Alzamend Neuro Inc (ALZN) indicator readings as of 2026-10-09.
ALZN's 14-day RSI is 33.1, in neutral territory. At $1.34 it is trading 13.1% below its 200-day moving average of $1.54, and below its 50-day average of $1.60. Price sits near the lower Bollinger Band ($1.20 to $2.14). ADX reads 36.7, indicating a trending market.
Overview
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
Finance Bot
Ask your questions
Start by typing a question below.
